Search research articles
Contact Us
Filters
Showing results (151-160 of 218) with videos related to
Page
of 22
Sort By:
Nature Communications
|
September 4, 2023
The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer
Alexander J Ohnmacht, Arndt Stahler, Sebastian Stintzing, et al.
Oncotarget
|
December 30, 2017
Exploring the effect of primary tumor sidedness on therapeutic efficacy across treatment lines in patients with metastatic colorectal cancer: analysis of FIRE-3 (AIOKRK0306)
Dominik Paul Modest, Sebastian Stintzing, Ludwig Fischer von Weikersthal, et al.
Oncology Research and Treatment
|
June 1, 2025
Guidelines of Onkopedia: What Is New?
Magdalena K Scheck, Salah-Eddin Al-Batran, Markus Borner, et al.
JMIR Research Protocols
|
April 21, 2023
Digital Guardian Angel Supported by an Artificial Intelligence System to Improve Quality of Life, Well-being, and Health Outcomes of Patients With Cancer (ONCORELIEF): Protocol for a Single Arm Prospective Multicenter Pilot Study
Joaquim Reis, Luzia Travado, Alexander Scherrer, et al.
British Journal of Cancer
|
November 6, 2020
FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial
Volker Heinemann, Ludwig Fischer von Weikersthal, Thomas Decker, et al.
Oncoimmunology
|
September 14, 2020
Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC)
Carl Christoph Schimanski, Stefan Kasper, Susanna Hegewisch-Becker, et al.
Human Gene Therapy
|
September 6, 2017
Virotherapy Research in Germany: From Engineering to Translation
Guy Ungerechts, Christine E Engeland, Christian J Buchholz, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
September 7, 2014
International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus
Markus Moehler, Christoph T H Baltin, Matthias Ebert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 18, 2020
Amphiregulin Expression Is a Predictive Biomarker for <i>EGFR</i> Inhibition in Metastatic Colorectal Cancer: Combined Analysis of Three Randomized Trials
Arndt Stahler, Sebastian Stintzing, Dominik P Modest, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 30, 2025
Impact of sex on efficacy and safety of 1st-line treatment with FOLFIRI plus cetuximab or bevacizumab in RAS/BRAF wildtype metastatic colorectal cancer - A subgroup analysis of the FIRE-3 (AIO KRK-0306) trial
Kathrin Heinrich, Sebastian Stintzing, Ludwig Fischer von Weikersthal, et al.
Page
of 22
Search research articles
Search
Showing results (151-160 of 218) with videos related to
Sort By:
Page
of 22
Nature Communications
|
September 4, 2023
The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer
Alexander J Ohnmacht, Arndt Stahler, Sebastian Stintzing, et al.
Oncotarget
|
December 30, 2017
Exploring the effect of primary tumor sidedness on therapeutic efficacy across treatment lines in patients with metastatic colorectal cancer: analysis of FIRE-3 (AIOKRK0306)
Dominik Paul Modest, Sebastian Stintzing, Ludwig Fischer von Weikersthal, et al.
Oncology Research and Treatment
|
June 1, 2025
Guidelines of Onkopedia: What Is New?
Magdalena K Scheck, Salah-Eddin Al-Batran, Markus Borner, et al.
JMIR Research Protocols
|
April 21, 2023
Digital Guardian Angel Supported by an Artificial Intelligence System to Improve Quality of Life, Well-being, and Health Outcomes of Patients With Cancer (ONCORELIEF): Protocol for a Single Arm Prospective Multicenter Pilot Study
Joaquim Reis, Luzia Travado, Alexander Scherrer, et al.
British Journal of Cancer
|
November 6, 2020
FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial
Volker Heinemann, Ludwig Fischer von Weikersthal, Thomas Decker, et al.
Oncoimmunology
|
September 14, 2020
Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC)
Carl Christoph Schimanski, Stefan Kasper, Susanna Hegewisch-Becker, et al.
Human Gene Therapy
|
September 6, 2017
Virotherapy Research in Germany: From Engineering to Translation
Guy Ungerechts, Christine E Engeland, Christian J Buchholz, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
September 7, 2014
International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus
Markus Moehler, Christoph T H Baltin, Matthias Ebert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 18, 2020
Amphiregulin Expression Is a Predictive Biomarker for <i>EGFR</i> Inhibition in Metastatic Colorectal Cancer: Combined Analysis of Three Randomized Trials
Arndt Stahler, Sebastian Stintzing, Dominik P Modest, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 30, 2025
Impact of sex on efficacy and safety of 1st-line treatment with FOLFIRI plus cetuximab or bevacizumab in RAS/BRAF wildtype metastatic colorectal cancer - A subgroup analysis of the FIRE-3 (AIO KRK-0306) trial
Kathrin Heinrich, Sebastian Stintzing, Ludwig Fischer von Weikersthal, et al.
Page
of 22